GLP-1RAs and GIP/GLP-1RAs linked to hair loss in pharmacovigilance data, causality unproven

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual gastric inhibitory polypeptide (GIP)/GLP-1RAs are transformative therapies for type 2 diabetes mellitus and obesity, improving glycemic control and promoting weight loss. While highly effective, the rapid expansion of their use, particularly in the USA and now Europe, necessitates a thorough understanding of all potential side effects. Recent safety signals have highlighted a possible association between these drugs and hair loss, a concern that requires careful evaluation to inform both clinicians and patients.

This commentary reviewed the emerging evidence concerning a potential link between GLP-1RA therapies and hair loss. The authors considered the pharmacological context and market expansion of these drugs. They specifically examined data primarily derived from pharmacovigilance database analyses and retrospective cohort studies to explore the strength of the association, potential pathophysiological mechanisms, and to propose clinical recommendations for managing outcomes. No prospective, controlled studies were included, as none have specifically evaluated this issue.

Most evidence suggesting a potential association between GLP-1RAs and hair loss stems from pharmacovigilance database analyses and retrospective cohort studies. The evidence indicating an increased risk of hair loss is strongest for semaglutide and tirzepatide, which are known for inducing significant weight loss. One primary potential underlying mechanism identified is the rapid weight loss often observed with these drugs, which could trigger telogen effluvium. This condition causes hair follicles to enter the resting (telogen) phase prematurely, leading to increased shedding. However, despite cases of hair loss being noted across diverse settings and multiple analyses, causality has not been definitively established. > Although cases of hair loss have been noted across diverse settings and multiple analyses, causality has not been established.